Advertisement

Topics

Fujirebio Inc. Company Profile

11:22 EST 19th November 2018 | BioPortfolio

Founded in 1950, Fujirebio Inc. is an international leading diagnostic supplier, a part of Miraca Group, Japan’s leading healthcare group with its focus on clinical laboratory testing services and products. Fujirebio is specialized in development, commercialization, import and export of diagnostic reagent and instruments. For more about Fujirebio, visit https://www.fujirebio-us.com/.


News Articles [4 Associated News Articles listed on BioPortfolio]

FDA approves Fujirebio's Lumipulse G B•R•A•H•M•S PCT assay

Fujirebio Diagnostics, a consolidated subsidiary of Miraca Holdings, has secured approval from the US Food and Drug Administration (FDA) for its Lumipulse G B•R•A•H•M•S procalcitonin (PCT) a...

Fujirebio Diagnostics Announces FDA Clearance of Lumipulse G B•R•A•H•M•S PCT Assay

Testing for Change in PCT Levels Assists with Antibiotic Stewardship and Risk Assessment Of Lower Respiratory Tract Infections and Sepsis Fujirebio Diagnostics, Inc., a...

Fujirebio Europe NV Strategic SWOT Analysis Review [Report Updated: 27032018] Prices from USD $125

Fujirebio Europe NV Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed S...

Fujirebio Diagnostics Inc Product Pipeline Analysis, 2018 Update [Report Updated: 16082018] Prices from USD $750

SummaryFujirebio Diagnostics Inc FDI, a subsidiary of Fujirebio Inc is a healthcare diagnostic company that manufactures, markets and develops biomarker assays and invitro diagnostic products. The com...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [6 Associated Companies listed on BioPortfolio]

Fujirebio Inc.

Founded in 1950, Fujirebio Inc. is an international leading diagnostic supplier, a part of Miraca Group, Japan’s leading healthcare group with its focus on clinical laborator...

Fujirebio Diagnostics, Inc.

Fujirebio Diagnostics, Inc., a subsidiary of Fujirebio Holdings, Inc., is the premier cancer diagnostics company and the industry leader in cancer biomarker assays. The company pi...

Fujirebio Diagnostics,Inc

Formerly Certocor Diagnostics,Fujirebio Diagnostics,Inc.was acquired by ourparent company Fujirebio,Inc.of Tokyo,Japan in November 1998.

JFK Communications, Inc.

Fujirebio Diagnostics is the premier cancer diagnostics company and the industry leader in cancer biomarker assays. Fujirebio Diagnostics specializes in the clinical development, manufacturing and co...

Gold Standard Diagnostics, Corp.

Fujirebio Diagnostics is the premier cancer diagnostics company and the industry leader in cancer biomarker assays. Fujirebio Diagnostics specializes in the clinical development, ...

More Information about "Fujirebio Inc." on BioPortfolio

We have published hundreds of Fujirebio Inc. news stories on BioPortfolio along with dozens of Fujirebio Inc. Clinical Trials and PubMed Articles about Fujirebio Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Fujirebio Inc. Companies in our database. You can also find out about relevant Fujirebio Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record